Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis

Background In patients with stage 0–A (as per Milan criteria) hepatocellular carcinoma (HCC) image-guided ablation is less invasive and requires shorter hospitalization than resection, but long-term prognosis is poorer. This meta-analysis was conducted to investigate whether liver stiffness measurem...

Full description

Bibliographic Details
Main Authors: Yongchao Zhang, Hualei Chen, Shanshan Chen, Wei Li
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:http://dx.doi.org/10.1080/02656736.2021.1947529
_version_ 1819319866935476224
author Yongchao Zhang
Hualei Chen
Shanshan Chen
Wei Li
author_facet Yongchao Zhang
Hualei Chen
Shanshan Chen
Wei Li
author_sort Yongchao Zhang
collection DOAJ
description Background In patients with stage 0–A (as per Milan criteria) hepatocellular carcinoma (HCC) image-guided ablation is less invasive and requires shorter hospitalization than resection, but long-term prognosis is poorer. This meta-analysis was conducted to investigate whether liver stiffness measurement (LSM) could be used to predict prognosis in HCC patients after tumor ablation. Methods A literature search was conducted for all studies published till July 2020 in PubMed, Web of Science, Cochrane Library and EMBASE. Studies were included if they investigated the association between pretreatment LSM and prognosis in HCC patients treated with ablation. Subgroup analysis, meta-regression, publication bias assessment and sensitivity were conducted. Results Eight studies (with a total of 1276 HCC patients) were included in this meta-analysis. All patients were treated with radiofrequency ablation. Pooled results showed that high pretreatment LSM were associated with poor overall survival (OS) (hazard ratio [HR] = 4.31, 95% confidence interval [CI]: 2.27–8.20, p < .001) and recurrence-free survival (RFS), regardless of whether LSM was considered as a categorical variable (HR = 2.63, 95% CI = 1.63–4.22, p < .001) or as a continuous variable (HR = 1.02, 95% CI = 1.01–1.04, p = .003). Among studies treating LSM value as a categorical variable, liver stiffness measured using acoustic radio force impulse (ARFI) or transient elastography (TE) was significantly associated with RFS, but not liver stiffness measured using two-dimensional shear wave elastography (SWE). Conclusions High baseline LSM value appears to be associated with poor prognosis in HCC patients treated with radiofrequency ablation.
first_indexed 2024-12-24T11:10:30Z
format Article
id doaj.art-00dd3922ae1641ef8df38a3700ed4bad
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-12-24T11:10:30Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-00dd3922ae1641ef8df38a3700ed4bad2022-12-21T16:58:32ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572021-01-013811052105910.1080/02656736.2021.19475291947529Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysisYongchao Zhang0Hualei Chen1Shanshan Chen2Wei Li3Cancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityCancer Center, Beijing Ditan Hospital, Capital Medical UniversityBackground In patients with stage 0–A (as per Milan criteria) hepatocellular carcinoma (HCC) image-guided ablation is less invasive and requires shorter hospitalization than resection, but long-term prognosis is poorer. This meta-analysis was conducted to investigate whether liver stiffness measurement (LSM) could be used to predict prognosis in HCC patients after tumor ablation. Methods A literature search was conducted for all studies published till July 2020 in PubMed, Web of Science, Cochrane Library and EMBASE. Studies were included if they investigated the association between pretreatment LSM and prognosis in HCC patients treated with ablation. Subgroup analysis, meta-regression, publication bias assessment and sensitivity were conducted. Results Eight studies (with a total of 1276 HCC patients) were included in this meta-analysis. All patients were treated with radiofrequency ablation. Pooled results showed that high pretreatment LSM were associated with poor overall survival (OS) (hazard ratio [HR] = 4.31, 95% confidence interval [CI]: 2.27–8.20, p < .001) and recurrence-free survival (RFS), regardless of whether LSM was considered as a categorical variable (HR = 2.63, 95% CI = 1.63–4.22, p < .001) or as a continuous variable (HR = 1.02, 95% CI = 1.01–1.04, p = .003). Among studies treating LSM value as a categorical variable, liver stiffness measured using acoustic radio force impulse (ARFI) or transient elastography (TE) was significantly associated with RFS, but not liver stiffness measured using two-dimensional shear wave elastography (SWE). Conclusions High baseline LSM value appears to be associated with poor prognosis in HCC patients treated with radiofrequency ablation.http://dx.doi.org/10.1080/02656736.2021.1947529hepatocellular carcinomaliver stiffnessradiofrequency ablationmeta-analysis
spellingShingle Yongchao Zhang
Hualei Chen
Shanshan Chen
Wei Li
Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
International Journal of Hyperthermia
hepatocellular carcinoma
liver stiffness
radiofrequency ablation
meta-analysis
title Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
title_full Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
title_fullStr Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
title_full_unstemmed Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
title_short Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis
title_sort prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma hcc treated by radiofrequency ablation a meta analysis
topic hepatocellular carcinoma
liver stiffness
radiofrequency ablation
meta-analysis
url http://dx.doi.org/10.1080/02656736.2021.1947529
work_keys_str_mv AT yongchaozhang prognosticvalueofliverstiffnessmeasurementinpatientswithhepatocellularcarcinomahcctreatedbyradiofrequencyablationametaanalysis
AT hualeichen prognosticvalueofliverstiffnessmeasurementinpatientswithhepatocellularcarcinomahcctreatedbyradiofrequencyablationametaanalysis
AT shanshanchen prognosticvalueofliverstiffnessmeasurementinpatientswithhepatocellularcarcinomahcctreatedbyradiofrequencyablationametaanalysis
AT weili prognosticvalueofliverstiffnessmeasurementinpatientswithhepatocellularcarcinomahcctreatedbyradiofrequencyablationametaanalysis